J.A. Hartley

502 total citations
22 papers, 424 citations indexed

About

J.A. Hartley is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, J.A. Hartley has authored 22 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in J.A. Hartley's work include DNA and Nucleic Acid Chemistry (8 papers), Cancer therapeutics and mechanisms (7 papers) and Synthesis and Biological Evaluation (4 papers). J.A. Hartley is often cited by papers focused on DNA and Nucleic Acid Chemistry (8 papers), Cancer therapeutics and mechanisms (7 papers) and Synthesis and Biological Evaluation (4 papers). J.A. Hartley collaborates with scholars based in United Kingdom, United States and Italy. J.A. Hartley's co-authors include Robert L. Souhami, Neil W. Gibson, Mark Berardini, John Butler, John P. Bingham, Stephen Forrow, Simon McAdam, Stuart H. Yuspa, Moses Lee and Keith Grimaldi and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Biochemistry.

In The Last Decade

J.A. Hartley

22 papers receiving 414 citations

Peers

Countries citing papers authored by J.A. Hartley

Since Specialization

Citations

This map shows the geographic impact of J.A. Hartley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. Hartley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. Hartley more than expected).

Fields of papers citing papers by J.A. Hartley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.A. Hartley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. Hartley. The network helps show where J.A. Hartley may publish in the future.

Co-authorship network of co-authors of J.A. Hartley

This figure shows the co-authorship network connecting the top 25 collaborators of J.A. Hartley. A scholar is included among the top collaborators of J.A. Hartley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.A. Hartley. J.A. Hartley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	526 A potent PBD-heterocyclic polyamide conjugate targeting an ICB2 transcription factor binding site 2010 ·European Journal of Cancer Supplements ·(unknown), (unknown), Geoffrey Wells, Terence C. Jenkins, Tom Ellis, (unknown), Daniel Hochhauser, J.A. Hartley, Philip W. Howard, (unknown)	1
2	Preliminary results of a Cancer Research UK phase I trial combining the dinitrobenzamide prodrug CB1954 (tretazicar) and the NQO2 substrate EP-0152R (caricotamide) intravenously (IV) every 3 weeks 2008 ·Journal of Clinical Oncology ·Debashis Sarker, David A. Anderson, Victoria J. Spanswick, (unknown), Roshan Agarwal, (unknown), DJ Kerr, J.A. Hartley, Ian Judson, Mark R. Middleton	2
3	Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cells 2007 ·British Journal of Cancer ·Chris Pepper, Helen L. Lowe, Chris Fegan, Christophe Thurieau, David E. Thurston, J.A. Hartley, Patrick Delavault	17
4	263 Enhanced Repair of DNA Interstrand Crosslinking in Ovarian Cancer Cells From Patients Following Treatment With Platinumbased Chemotherapy 2004 ·International Journal of Gynecological Cancer ·(unknown), Tim Mould, A Olaitan, J.A. Hartley, Jonathan A. Ledermann	2
5	Synthesis of new bifunctional compounds which selectively alkylate guanines in DNA. 1998 ·PubMed ·(unknown), (unknown), C. Caroline O’Hare, J.A. Hartley, Siobhán McClean, L. P. G. Wakelin, Lloyd R. Kèlland, D. J. ROBINS	3
6	The sequence specificity of alkylation for a series of benzoic acid mustard and imidazole-containing distamycin analogues: the importance of local sequence conformation 1997 ·Nucleic Acids Research ·Michael D. Wyatt, (unknown), J.A. Hartley	3
7	In vitro Photoinduced Cytotoxicity and DNA Binding Properties of Psoralen and Coumarin Conjugates of Netropsin Analogs: DNA Sequence-Directed Alkylation and Cross-Link Formation 1994 ·Journal of Medicinal Chemistry ·Moses Lee, (unknown), (unknown), Simon McAdam, J.A. Hartley	25
8	DNA damage by anti-cancer agents resolved at the nucleotide level of a single copy gene: evidence for a novel binding site for cisplatin in cells 1994 ·Nucleic Acids Research ·Keith Grimaldi, Simon McAdam, Robert L. Souhami, J.A. Hartley	37
9	GC Sequence Specific Recognition by an N-Formamido, C-Terminus-Modified and Imidazole-Containing Analog of Netropsin 1994 ·Journal of Medicinal Chemistry ·Moses Lee, C. Preti, (unknown), Michael D. Wyatt, J.A. Hartley	6
10	In vitro cytotoxicity of GC sequence directed alkylating agents related to distamycin 1993 ·Journal of Medicinal Chemistry ·Moses Lee, (unknown), Michael D. Wyatt, Maurizio D’Incalci, Stephen Forrow, J.A. Hartley	37
11	Two structurally related diaziridinylbenzoquinones preferentially cross-link DNA at different sites upon reduction with DT-diaphorase 1993 ·Biochemistry ·Mark Berardini, Robert L. Souhami, (unknown), Neil W. Gibson, John Butler, J.A. Hartley	32
12	DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards is preserved in intact cells 1992 ·Nucleic Acids Research ·J.A. Hartley, John P. Bingham, Robert L. Souhami	46
13	Alteration in DNA cross-linking and sequence selectivity of a series of aziridinylbenzoquinones after enzymic reduction by DT-diaphorase 1992 ·Biochemistry ·(unknown), J.A. Hartley, Mark Berardini, John Butler, David Siegel, David Ross, Neil W. Gibson	45
14	Potentiation of etoposide-induced cytotoxicity and DNA damage in CCRF-CEM cells by pretreatment with non-cytotoxic concentrations of arabinosyl cytosine 1992 ·Cancer Chemotherapy and Pharmacology ·Christine M. Chresta, (unknown), J.A. Hartley, Robert L. Souhami	8
15	DNA crosslinking and sequence selectivity of aziridinylbenzoquinones: a unique reaction at 5'-GC-3' sequences with 2,5-diaziridinyl-1,4-benzoquinone upon reduction 1991 ·Biochemistry ·J.A. Hartley, Mark Berardini, Mauro Ponti, Neil W. Gibson, Andrew S. Thompson, David E. Thurston, Brigid M. Hoey, John Butler	33
16	Liblomycin-mediated DNA cleavage in human head and neck squamous carcinoma cells and purified DNA. 1990 ·PubMed ·Karsten Wassermann, (unknown), J. William Lown, J.A. Hartley, Kiyohiro Nishikawa, Jia‐Ren Lin, Robert A. Newman	3
17	Effect of ionic strength and cationic DNA affinity binders on the DNA sequence selective alkylation of guanine N7-positions by nitrogen mustards 1990 ·Biochemistry ·J.A. Hartley, Stephen Forrow, Robert L. Souhami	22
18	Photosensitization of human leukemic cells by anthracenedione antitumor agents. 1990 ·PubMed ·J.A. Hartley, (unknown), R L Souhami, K. Reszka, J. W. LOWN	22
19	Molecular recognition between oligopeptides and nucleic acids rational design of sequence specific dna binding agents 1988 ·Krzysztof Krowicki, (unknown), J.A. Hartley, Brian Ward, (unknown), Andrew Skorobogaty, James C. Dabrowiak, J. William Lown	5
20	Association of DNA strand breaks with accelerated terminal differentiation in mouse epidermal cells exposed to tumor promoters. 1985 ·PubMed ·J.A. Hartley, Neil W. Gibson, (unknown), Stuart H. Yuspa	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact